Topotecan versus treosulfan, an alkylating agent, in patients with epithelial ovarian cancer and relapse within 12 months following 1st-line platinum/paclitaxel chemotherapy. A prospectively randomized phase III trial by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR)

✍ Scribed by Werner Meier; Andreas du Bois; Alexander Reuss; Walther Kuhn; Sigrid Olbricht; Martina Gropp; Barbara Richter; Hans-Joachim Lück; Rainer Kimmig; Jacobus Pfisterer

• Book ID: 113962053
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 545 KB
• Volume: 114
• Category: Article
• ISSN: 0090-8258
• DOI: 10.1016/j.ygyno.2009.04.026